EP1572336A1 - Device for producing medical foam - Google Patents
Device for producing medical foamInfo
- Publication number
- EP1572336A1 EP1572336A1 EP03795826A EP03795826A EP1572336A1 EP 1572336 A1 EP1572336 A1 EP 1572336A1 EP 03795826 A EP03795826 A EP 03795826A EP 03795826 A EP03795826 A EP 03795826A EP 1572336 A1 EP1572336 A1 EP 1572336A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- foam
- chamber
- foam generator
- gas
- connecting element
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/50—Movable or transportable mixing devices or plants
- B01F33/501—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use
- B01F33/5011—Movable mixing devices, i.e. readily shifted or displaced from one place to another, e.g. portable during use portable during use, e.g. hand-held
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/30—Injector mixers
- B01F25/31—Injector mixers in conduits or tubes through which the main component flows
- B01F25/311—Injector mixers in conduits or tubes through which the main component flows for mixing more than two components; Devices specially adapted for generating foam
- B01F25/3111—Devices specially adapted for generating foam, e.g. air foam
- B01F25/31112—Devices specially adapted for generating foam, e.g. air foam with additional mixing means other than injector mixers, e.g. screen or baffles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/451—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by means for moving the materials to be mixed or the mixture
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F25/00—Flow mixers; Mixers for falling materials, e.g. solid particles
- B01F25/40—Static mixers
- B01F25/45—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads
- B01F25/452—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces
- B01F25/4522—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through porous bodies, e.g. flat plates, blocks or cylinders, which obstruct the whole diameter of the tube
- B01F25/45221—Mixers in which the materials to be mixed are pressed together through orifices or interstitial spaces, e.g. between beads characterised by elements provided with orifices or interstitial spaces the components being pressed through porous bodies, e.g. flat plates, blocks or cylinders, which obstruct the whole diameter of the tube the porous bodies being cylinders or cones which obstruct the whole diameter of the tube, the flow changing from axial in radial and again in axial
Definitions
- the invention relates to a device for producing, in particular, reproducible medical foam or vesicle suspension from a gaseous and a liquid medium.
- the invention relates to a mixing device for the reproducible preparation and administration of injectables - such as e.g. Sclerosing agents, diagnostics, therapeutics, homeopathics and autologous blood.
- Sclerotherapy is the planned elimination of intra-, subcutaneous and / or transfascial varices and the sclerotherapy of subfascial vessels in the event of venous malformations by injecting a sclerosing agent.
- the various sclerosing agents damage the endothelium of the vessels. This is followed by a secondary vascular occlusion and, in the long term, the veins are transformed into a connective tissue strand, sclerosis.
- Sclerotherapy is aimed at. definitive transformation into a fibrous strand. This cannot recanalize and its functional result corresponds to the surgical procedure for removing a varice.
- the obliteration with foamed sclerosing agents is becoming increasingly important.
- the foam stays in the vein longer.
- Surface-active sclerosing agents such as polidocanol, are usually brought into a foam-like state by pumping back and forth between two syringes or by shaking, and then conventionally injected. There is currently no approved procedure that enables the reproducible preparation of a standardized foam.
- echo contrast media are known, some of which are: Contain surface-active substances that support the formation of microbubbles and stabilize them.
- the ultrasound reflecting microbubbles or a foam are the actual contrast agent and are only generated immediately before administration.
- a mixing device for producing medical foam or for producing bubbles is known from EP 0 564 505.
- This describes a mixer with a helical mixing element.
- the mixer is an additional element that can be permanently connected to a syringe.
- the medium enters the mixer, which contains the gas in a defined volume and type.
- the gas phase and liquid phase are mixed along the helical mixing element. Thereby a therapeutic and / or diagnostic foam can be generated.
- the mixing device described in EP 0 564 505 has the disadvantage that the mixer firmly connected to the syringe, particularly when moving the solution back and forth, can easily break off or be tilted due to the long lever. Furthermore, the mixer is a component which, owing to the spiral mixing elements arranged in the mixer, can only be produced using complex injection molds as an injection molded part.
- the object of the invention is to provide a device with which medical foam can be produced in a simple manner from a gaseous and a liquid medium. According to the invention, the object is achieved by the features of claim 1.
- the device according to the invention has an active ingredient chamber and a gas chamber. Both chambers are closed with a piston. Furthermore, the device has a foam generator, which in particular has one or more screens. Both the active ingredient chamber and the gas chamber are directly or indirectly connected to the foam generator. According to the invention, the two pistons are arranged displaceably in the respective chamber. In particular, the two pistons are connected to one another or can be connected while the device is actuated, so that the two pistons are each displaced together in one of the two chambers. This results in an increase in the pressure in the chambers and thus a conveyance or transport of the active ingredient and the gas in the direction of the foam generator or through the foam generator. The device according to the invention is thus very easy to handle, since both pistons are moved by one movement and thus both media are pressed or transported in the direction of the foam generator. The medical foam emerging from the foam generator then only has to be collected, but can also be applied directly.
- a back and forth movement of a gas and a liquid or a gas and a detergent between two syringes is not necessary.
- the production of a standardized sterile foam is therefore considerably easier.
- the provision of a pressurized gas container is not necessary in the device according to the invention.
- the two pistons are preferably connected to one another via a connecting element.
- the connecting element is preferably designed such that one of the two chambers is opened when the connecting element is moved. Furthermore, by moving the Connection element connecting the two pistons.
- the two pistons are preferably connected only by actuating the device. This has the advantage that the two chambers are completely separate from one another and can be sealed off.
- the connecting element is particularly preferred here to design the connecting element as a delivery channel, for example as a hollow needle. By moving the connecting element together with one of the two pistons, the connecting channel is introduced into one of the two chambers. If the connecting element is designed as a hollow needle, one of the two chambers is pierced by the hollow needle, for example, piercing through the second piston.
- a driving element on the connecting element which in particular can be designed as a bead or plate. This makes it possible, when moving the connecting element in the direction of one of the two pistons closing the chambers after, for example, piercing or opening the piston, to press the latter into the corresponding chamber and thus to increase the pressure in the chamber, so that the pressure in the chamber Medium preferably flows into the hollow needle and through this to the foam generator.
- One of the two pistons is preferably, in particular, firmly connected to the foam generator. Furthermore, one of the two pistons can also be loosely connected to the foam generator.
- the medium preferably flows through the piston into the foam generator. It is further preferred that the medium from the second chamber also passes through this piston flowing.
- the two media preferably mix in the foam generator and / or immediately before the foam generator. It is particularly preferred to press the medium out of the chamber further away from the foam generation through a delivery channel provided in the connecting element and to feed it at least partially directly to the foam generator. In this embodiment, the two media are mixed directly in the foam generator. Possibly.
- a mixing element can be provided in or in front of the foam generator, in which the two media are premixed before they are pressed by the foam generator.
- This mixing element can be, for example, a type of sponge or a sintered material which at the same time serves to brake the active substance. This improves foam generation.
- foam generator inside the syringe, for example in the attachment which e.g. also trains the Luer lock to provide.
- a foam outlet opening of the foam generator can preferably be connected to a foam collecting container.
- the foam collecting container can, for example, be a conventional syringe, which can then be connected to the foam outlet opening, for example via a Luer lock.
- the device according to the invention is particularly suitable for single-use because of its simple and inexpensive construction of preferably individually producible simple parts.
- the required sterility can be guaranteed, in particular due to the disposable use.
- Another advantage of the device according to the invention is that the medicament and the gas come into contact with one another only immediately before application.
- Fig. 1-3 is a schematic, partially sectioned side view of the device in three different mixing states
- Fig. 4 is a schematic exploded view of the invention
- the device according to the invention for producing medical foam has an active ingredient chamber 10 and a gas chamber 12.
- the active ingredient chamber 10 is designed as a carpule 14 (FIG. 4) and is sealed with a first piston 16, which can be a rubber stopper or the like.
- the carpule 14 is held in a holder 18, in which the carpule 14 in the direction of an arrow 20 in the holder 18 in the in Figs. 1 - 3 position is inserted.
- the carpule 14 is hereby fixed in position by latching elements 22 and stops 24 (FIG. 4) arranged opposite the latching elements 22.
- the holder 18, which receives in the cylindrical opening 26, which preferably also has a circular cylindrical carpule 14, is connected to a cylindrical extension 28.
- the gas chamber 12 is formed within the cylindrical projection 28.
- the gas chamber 12 is also tightly closed by a second piston 30.
- the gas chamber can optionally also be designed as a carpule.
- the likewise cylindrical gas chamber 12 has a larger diameter than the active substance chamber 10.
- the provision of active ingredient or gas in the two chambers can also be interchanged. This is particularly expedient in the case of active ingredients in which only a small amount of gas is required for foaming, ie for active ingredients that are themselves easily foamable.
- the height of the gas chamber 12 and of the active substance chamber 10 is essentially the same, the gas chamber 12 preferably being slightly higher in order to be able to completely empty both chambers 10, 12, if the pistons 16, 30 are fully pushed in.
- a connecting element 32 designed as a hollow needle is connected to the second piston 30.
- the piston 30 has a suitable, for example cylindrical extension 34 (FIG. 4) into which the hollow needle 32 can be inserted and is held, for example, by gluing.
- a foam generator 38 is fixedly or loosely and optionally detachably connected to the piston 30, which bears sealingly on the inner wall 36 of the gas chamber 12.
- the foam generator 38 has, in particular, two sieves 40 which cause the two media to swirl and mix and thus produce foam.
- the foam generator 38 is connected to the piston 30 via a holder 42.
- the foam generator 38 can also each have one or more sintered filters, propellers, helices and / or spirals, for example.
- a loose or detachable connection of the foam generator 38 to the piston 30 has the advantage that the foam generator 38 can be pulled out of the cylindrical extension 38 of the device according to the invention together with the syringe 46.
- the foam is pressed out of the syringe 46, it is pressed again by the foam generator 38, so that the quality of the foam produced can be further improved.
- locking elements it is possible for locking elements to be provided on the inside of the cylindrical extension 28, by means of which it is prevented that the piston 30 can be pulled out of the cylindrical extension 28.
- the piston 30 can have latching elements, for example in recesses engage, which are provided on the extension 28 when the piston 30 is pulled too far out of the extension 28.
- the holder 42 has a foam outlet opening 44 (FIG. 4) through which the foam generated in the foam generator 38 exits.
- the foam outlet opening is a luer to which a conventional syringe 46 can be connected.
- the syringe 46 serves here as a foam collecting container, as shown in FIGS. 2 and 3 can be seen.
- the holder 18 is placed on a base, so that the device, as shown in FIGS. 1-3, is vertically aligned. Then the syringe body is e.g. with the help of approaches 48 in FIGS. pressed down in the direction of an arrow 50. The position of the syringe plunger or syringe plunger 52 is not changed.
- the foam generator 38 and the second piston 30 are moved downwards. Together with the piston 30, the hollow needle 32 firmly connected to the piston 30 is pushed downward.
- a tip 54 of the hollow needle 32 pierces the first piston 16 and thus opens the active substance chamber 10.
- a driving element 56 such as a plate
- the plate 56 presses the first piston 16 into the active substance chamber 10.
- the displacement of the two pistons 30, 16 both increases the pressure in the active substance chamber 10 and also in the gas chamber 12.
- active substance is pressed through the hollow needle 32 into the foam generator 38.
- gas from the gas chamber 12 is pressed into the foam generator 38 through openings 58 which are located in the piston 30 and / or through transverse bores in the hollow needle 32.
- the resulting foam passes through the foam outlet opening 44 of the Foam generator 38 in the space 60 free by the movement of the syringe body within the syringe body.
- a major advantage of the device according to the invention is that a single piston stroke, i.e. that in Figs. 1 - 3 downward pressing of the two pistons 16, 30 creates a foam in the syringe 46.
- the syringe 46 can be detached from the Luer adapter after the foam has been generated, so that the foam can then be applied immediately.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE20218493U | 2002-11-28 | ||
DE20218493U DE20218493U1 (en) | 2002-11-28 | 2002-11-28 | Device for producing medical foam |
PCT/EP2003/012894 WO2004047969A1 (en) | 2002-11-28 | 2003-11-13 | Device for producing medical foam |
Publications (3)
Publication Number | Publication Date |
---|---|
EP1572336A1 true EP1572336A1 (en) | 2005-09-14 |
EP1572336B1 EP1572336B1 (en) | 2006-03-15 |
EP1572336B2 EP1572336B2 (en) | 2018-01-24 |
Family
ID=32103522
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03795826.1A Expired - Lifetime EP1572336B2 (en) | 2002-11-28 | 2003-11-13 | Device for producing medical foam |
Country Status (7)
Country | Link |
---|---|
US (1) | US7963938B2 (en) |
EP (1) | EP1572336B2 (en) |
AT (1) | ATE320304T1 (en) |
AU (1) | AU2003298123A1 (en) |
DE (2) | DE20218493U1 (en) |
ES (1) | ES2260686T3 (en) |
WO (1) | WO2004047969A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9912356D0 (en) | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
GB0028692D0 (en) | 2000-11-24 | 2001-01-10 | Btg Int Ltd | Generation of therapeutic microform |
US8512680B2 (en) | 2001-08-08 | 2013-08-20 | Btg International Ltd. | Injectables in foam, new pharmaceutical applications |
DE20218493U1 (en) | 2002-11-28 | 2004-04-08 | Chemische Fabrik Kreussler & Co. Gmbh | Device for producing medical foam |
PL1701701T5 (en) | 2003-11-17 | 2021-07-26 | Btg International Limited | Methods of preparing a foam comprising a sclerosing agent |
US8048086B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8048101B2 (en) | 2004-02-25 | 2011-11-01 | Femasys Inc. | Methods and devices for conduit occlusion |
US8052669B2 (en) | 2004-02-25 | 2011-11-08 | Femasys Inc. | Methods and devices for delivery of compositions to conduits |
US9238127B2 (en) | 2004-02-25 | 2016-01-19 | Femasys Inc. | Methods and devices for delivering to conduit |
DE102004048749B4 (en) * | 2004-10-05 | 2007-03-29 | Chemische Fabrik Kreussler & Co. Gmbh | Device for producing a medical foam |
DE102005011174B4 (en) | 2005-03-09 | 2022-03-24 | Chemische Fabrik Kreussler & Co. Gmbh | Device for generating a medical foam |
FR2883731B1 (en) * | 2005-03-31 | 2008-03-14 | Alain Monfreux | DEVICE FOR THE PRODUCTION OF FORMED FOAM OF GAS BUBBLES AND A SURFACE LIQUID |
GB0509845D0 (en) | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Preparation of therapeutic foam |
GB0509824D0 (en) | 2005-05-13 | 2005-06-22 | Btg Int Ltd | Therapeutic foam |
US8672879B2 (en) * | 2005-10-13 | 2014-03-18 | Argos Therapeutics, Inc. | Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures |
US8876749B2 (en) | 2006-11-27 | 2014-11-04 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
US20090318890A1 (en) * | 2006-11-27 | 2009-12-24 | Frank Levy | Portable Medical Foam Apparatus |
US9486594B2 (en) | 2006-11-27 | 2016-11-08 | Frank Levy | Portable medical gas delivery system |
US9662435B2 (en) | 2006-01-31 | 2017-05-30 | Frank Levy | System and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid |
US11833320B2 (en) | 2006-11-27 | 2023-12-05 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
US10155093B2 (en) | 2006-11-27 | 2018-12-18 | Frank Levy | Apparatus and method for producing CO2 enriched medical foam |
US11185671B2 (en) | 2006-11-27 | 2021-11-30 | Frank Levy | Apparatus and process for producing CO2 enriched medical foam |
US10350399B2 (en) | 2006-11-27 | 2019-07-16 | Frank Levy | Apparatus and method for producing an enriched medical suspension of carbon dioxide |
US9427522B2 (en) | 2006-11-27 | 2016-08-30 | Frank Levy | Delivery system for the effective and reliable delivery of controlled amounts of a medical fluid |
US10322271B2 (en) | 2006-11-27 | 2019-06-18 | Frank Levy | Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid |
US10149935B2 (en) | 2006-11-27 | 2018-12-11 | Frank Levy | Delivery system and method for the effective and reliable delivery of controlled amounts of a medical fluid |
US11712510B2 (en) | 2006-11-27 | 2023-08-01 | Frank Levy | Delivery system and method for the effective, reliable and foolproof delivery of controlled amounts of a medical fluid |
US10070888B2 (en) | 2008-10-03 | 2018-09-11 | Femasys, Inc. | Methods and devices for sonographic imaging |
US9554826B2 (en) | 2008-10-03 | 2017-01-31 | Femasys, Inc. | Contrast agent injection system for sonographic imaging |
CA2678198A1 (en) * | 2009-09-08 | 2011-03-08 | Duoject Medical Systems Inc. | Ez-linking device for fluid transfer |
US8449494B2 (en) * | 2009-12-16 | 2013-05-28 | Cook Medical Technologies Llc | Apparatus and method for preparing foam |
EP2508219B1 (en) * | 2011-04-05 | 2018-06-06 | Kpr U.S., Llc | Buffering agent delivery system for anesthetic syringe |
GB201612948D0 (en) * | 2016-07-26 | 2016-09-07 | Provensis Ltd | syringe for administering foam |
RU2659632C1 (en) * | 2017-04-04 | 2018-07-03 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Рязанский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации | Device for foaming and administering a medicament |
CN107096406B (en) * | 2017-05-11 | 2023-09-15 | 金宝医学科技(深圳)有限公司 | Micro-foam generating device and method |
WO2019233546A1 (en) * | 2018-06-04 | 2019-12-12 | Gemü Gmbh | Applicator |
CN111013423B (en) * | 2020-01-06 | 2024-06-14 | 中国人民解放军陆军军医大学第一附属医院 | Foaming device |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2630183A (en) * | 1950-01-26 | 1953-03-03 | Foutz Clinton Root | Apparatus for forming and projecting a foam mixture |
US2653607A (en) * | 1950-09-16 | 1953-09-29 | Ayerst Mckenna & Harrison | Injection apparatus |
US2724383A (en) * | 1951-06-28 | 1955-11-22 | Compule Corp | Combined mixing container structure and hypodermic syringe for segregated ingredients of hypodermically injectable preparations |
US2772677A (en) * | 1953-02-18 | 1956-12-04 | Izaak A Ulert | Syringe assembly |
US3248014A (en) * | 1964-10-07 | 1966-04-26 | Orville N Greene | Piston type dispenser |
DE1278703B (en) * | 1967-01-21 | 1968-09-26 | Penicillin Ges Dauelsberg & Co | Two-chamber syringe |
US3767085A (en) | 1971-08-02 | 1973-10-23 | J Cannon | Mixing syringe |
BE792131A (en) * | 1972-02-15 | 1973-03-16 | Sherwood Medical Ind Inc | DEVICES FOR INJECTING MEDICINES |
US4014463A (en) * | 1975-11-28 | 1977-03-29 | Kenics Corporation | Plural component dispenser |
US4059109A (en) * | 1976-07-27 | 1977-11-22 | Tischlinger Edward A | Mixing and dispensing disposable medicament injector |
US4538920A (en) * | 1983-03-03 | 1985-09-03 | Minnesota Mining And Manufacturing Company | Static mixing device |
DE3417182A1 (en) † | 1984-05-09 | 1985-11-14 | Gerald Dr. 8000 München Hauer | Syringe set |
US4743229A (en) * | 1986-09-29 | 1988-05-10 | Collagen Corporation | Collagen/mineral mixing device and method |
DE8916222U1 (en) * | 1988-09-29 | 1995-08-10 | AFA Products, Inc., Forest City, N.C. | Foam nozzle arrangement |
US5425580A (en) † | 1990-12-28 | 1995-06-20 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dosage form for micro-bubble echo contrast agents |
EP0564505B1 (en) | 1990-12-28 | 1995-06-21 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Dosage form for micro-bubble echo contrast agents |
CZ282096B6 (en) † | 1992-12-01 | 1997-05-14 | Tetsuro Higashikawa | Syringe |
US5827262A (en) * | 1993-09-07 | 1998-10-27 | Debiotech S.A. | Syringe device for mixing two compounds |
DE4338553A1 (en) * | 1993-11-08 | 1995-05-18 | Ferring Arzneimittel Gmbh | Injection syringe for mixing and applying injection substances |
US5454805A (en) * | 1994-03-14 | 1995-10-03 | Brony; Seth K. | Medicine vial link for needleless syringes |
DE4432993C1 (en) | 1994-09-16 | 1996-06-20 | Byk Gulden Lomberg Chem Fab | Mixing device for agents to be administered by means of a syringe |
FR2775433A1 (en) * | 1998-02-27 | 1999-09-03 | Alain Monfreux | DEVICE FOR PRODUCING FOAM IN A SYRINGE BODY |
GB9912356D0 (en) † | 1999-05-26 | 1999-07-28 | Btg Int Ltd | Generation of microfoam |
DE20015594U1 (en) * | 2000-09-08 | 2001-06-21 | Herrmann, Frank, 12619 Berlin | Device for infinitely variable, quantity and pressure-controlled entry of gas into liquid media |
GB0028692D0 (en) † | 2000-11-24 | 2001-01-10 | Btg Int Ltd | Generation of therapeutic microform |
GB2369996B (en) † | 2000-12-18 | 2004-06-23 | S T D Pharmaceutical Products | Method and apparatus for producing an injectable foam |
US6592251B2 (en) * | 2001-01-26 | 2003-07-15 | Howmedica Osteonics Corp. | Cement mixing and dispensing device |
DE20218493U1 (en) | 2002-11-28 | 2004-04-08 | Chemische Fabrik Kreussler & Co. Gmbh | Device for producing medical foam |
-
2002
- 2002-11-28 DE DE20218493U patent/DE20218493U1/en not_active Expired - Lifetime
-
2003
- 2003-11-13 EP EP03795826.1A patent/EP1572336B2/en not_active Expired - Lifetime
- 2003-11-13 AU AU2003298123A patent/AU2003298123A1/en not_active Abandoned
- 2003-11-13 ES ES03795826T patent/ES2260686T3/en not_active Expired - Lifetime
- 2003-11-13 US US10/536,862 patent/US7963938B2/en not_active Expired - Fee Related
- 2003-11-13 DE DE50302685T patent/DE50302685D1/en not_active Expired - Lifetime
- 2003-11-13 WO PCT/EP2003/012894 patent/WO2004047969A1/en not_active Application Discontinuation
- 2003-11-13 AT AT03795826T patent/ATE320304T1/en active
Non-Patent Citations (1)
Title |
---|
See references of WO2004047969A1 * |
Also Published As
Publication number | Publication date |
---|---|
DE50302685D1 (en) | 2006-05-11 |
WO2004047969A1 (en) | 2004-06-10 |
EP1572336B2 (en) | 2018-01-24 |
AU2003298123A1 (en) | 2004-06-18 |
US7963938B2 (en) | 2011-06-21 |
US20060178620A1 (en) | 2006-08-10 |
EP1572336B1 (en) | 2006-03-15 |
ES2260686T3 (en) | 2006-11-01 |
DE20218493U1 (en) | 2004-04-08 |
ATE320304T1 (en) | 2006-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1572336B1 (en) | Device for producing medical foam | |
DE69930615T2 (en) | COMPOSITION AND METHOD FOR THE DISPERSION AND PROVISION OF FLUIDS | |
EP1796761B2 (en) | Device for producing a medical foam | |
DE60209389T2 (en) | Storage and dispensing device for biological sealant | |
EP0454816B1 (en) | Injection device | |
EP1931405B1 (en) | Automatic injection device for two-chamber ampullas | |
DE69820916T2 (en) | Fibrin-based adhesive application device | |
DE69408837T2 (en) | METHOD AND DEVICE FOR PREPARING AND DELIVERING BONE CEMENT | |
DE69839128T2 (en) | DONOR ARRANGEMENT | |
DE69430131T2 (en) | INJECTION CARTRIDGE | |
DE69122391T2 (en) | INJECTION DEVICE FOR SUPPLYING NUTRITION | |
DE69125812T2 (en) | COVER FOR CANNULA | |
DE69332351T2 (en) | CANNULAS FOR USE IN MEDICINE DELIVERY SYSTEMS | |
EP1498073B1 (en) | System and procedure for mixing of at least four components | |
DE102010019217A1 (en) | Cartridge system and discharge tube for such a cartridge system | |
DE29580137U1 (en) | Two-part device for the administration of drugs | |
DE69923198T2 (en) | CATHETER, WHICH ALLOWS MIXING COMPONENTS | |
DE112007003084T5 (en) | Apparatus and method for the production of therapeutic foam | |
WO1997002060A1 (en) | Automatic cannula withdrawing device for injection syringes | |
WO1996008227A1 (en) | Mixing device for agents to be administered with a syringe | |
DE3417182C2 (en) | ||
DE10151104B4 (en) | Device for mixing two components | |
DE102004055298A1 (en) | Device for mixing injected medicine comprises an ampoule sleeve, a mixing sleeve, an abutment and a guiding unit having a power transmission structure which converts a linear into a rotary movement | |
EP1331031B1 (en) | Device for producing a medical foam | |
EP0379223B1 (en) | Disposable syringe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
17P | Request for examination filed |
Effective date: 20050415 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20060315 Ref country code: IE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP Ref country code: GB Ref legal event code: FG4D Free format text: NOT ENGLISH |
|
DAX | Request for extension of the european patent (deleted) | ||
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: LANGUAGE OF EP DOCUMENT: GERMAN |
|
REF | Corresponds to: |
Ref document number: 50302685 Country of ref document: DE Date of ref document: 20060511 Kind code of ref document: P |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20060517 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060615 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060615 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060615 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060816 |
|
NLV1 | Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act | ||
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2260686 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FD4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061130 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061130 |
|
PLBI | Opposition filed |
Free format text: ORIGINAL CODE: 0009260 |
|
PLAX | Notice of opposition and request to file observation + time limit sent |
Free format text: ORIGINAL CODE: EPIDOSNOBS2 |
|
26 | Opposition filed |
Opponent name: BTG INTERNATIONAL LIMITED Effective date: 20061215 |
|
PLAF | Information modified related to communication of a notice of opposition and request to file observations + time limit |
Free format text: ORIGINAL CODE: EPIDOSCOBS2 |
|
PLAS | Information related to reply of patent proprietor to notice(s) of opposition deleted |
Free format text: ORIGINAL CODE: EPIDOSDOBS3 |
|
PLBB | Reply of patent proprietor to notice(s) of opposition received |
Free format text: ORIGINAL CODE: EPIDOSNOBS3 |
|
BERE | Be: lapsed |
Owner name: CHEMISCHE FABRIK KREUSSLER & CO. G.M.B.H. Effective date: 20061130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060616 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071130 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20061113 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060916 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071130 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20060315 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20101119 Year of fee payment: 8 |
|
PLCK | Communication despatched that opposition was rejected |
Free format text: ORIGINAL CODE: EPIDOSNREJ1 |
|
APAH | Appeal reference modified |
Free format text: ORIGINAL CODE: EPIDOSCREFNO |
|
APBM | Appeal reference recorded |
Free format text: ORIGINAL CODE: EPIDOSNREFNO |
|
APBP | Date of receipt of notice of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA2O |
|
APBQ | Date of receipt of statement of grounds of appeal recorded |
Free format text: ORIGINAL CODE: EPIDOSNNOA3O |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MM01 Ref document number: 320304 Country of ref document: AT Kind code of ref document: T Effective date: 20111113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20111113 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20121123 Year of fee payment: 10 Ref country code: ES Payment date: 20121122 Year of fee payment: 10 Ref country code: GB Payment date: 20121122 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20131119 Year of fee payment: 11 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20131113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131113 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131113 |
|
PLAB | Opposition data, opponent's data or that of the opponent's representative modified |
Free format text: ORIGINAL CODE: 0009299OPPO |
|
R26 | Opposition filed (corrected) |
Opponent name: BTG INTERNATIONAL LIMITED Effective date: 20061215 |
|
APBU | Appeal procedure closed |
Free format text: ORIGINAL CODE: EPIDOSNNOA9O |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20150709 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20131114 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20150731 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20141201 |
|
PLAY | Examination report in opposition despatched + time limit |
Free format text: ORIGINAL CODE: EPIDOSNORE2 |
|
PLBC | Reply to examination report in opposition received |
Free format text: ORIGINAL CODE: EPIDOSNORE3 |
|
PLAY | Examination report in opposition despatched + time limit |
Free format text: ORIGINAL CODE: EPIDOSNORE2 |
|
PUAH | Patent maintained in amended form |
Free format text: ORIGINAL CODE: 0009272 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: PATENT MAINTAINED AS AMENDED |
|
27A | Patent maintained in amended form |
Effective date: 20180124 |
|
AK | Designated contracting states |
Kind code of ref document: B2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R102 Ref document number: 50302685 Country of ref document: DE |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20191202 Year of fee payment: 17 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 50302685 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210601 |